BEONE MEDICINES LTD-ADR (ONC:NASDAQ)
$312.31 -5.76 (-1.8109%)
Analysed BEONE MEDICINES LTD-ADR (ONC:NASDAQ) News Sources
BeOne Medicines price target lowered to $411 from $412 at Truist
09-04-2026
yahoo.com
BeOne Medicines (ONC) Is Up 9.4% After FDA Orphan Status And New Analyst Coverage For Liver Cancer
06-04-2026
yahoo.com
Wolfe Research Initiates Coverage of BeOne Medicines AG (ONC) with Outperform Rating
04-04-2026
yahoo.com
BeOne Medicines (ONC) Downgraded Despite Strong Oncology Portfolio
02-04-2026
yahoo.com
BeOne Medicines Ltd (ONC) Q4 2025 Earnings Call Highlights: Record Growth and Strategic Expansion
04-03-2026
yahoo.com
BeOne Medicines (ONC) Reports $1.5B Revenue for Q4, $1.1B from Lymphoma Treatment
01-03-2026
yahoo.com
Is It Time To Reassess BeOne Medicines (ONC) After Strong Multi Year Share Price Gains
26-02-2026
yahoo.com
Here's What Key Metrics Tell Us About BeOne Medicines Ltd. - Sponsored ADR (ONC) Q4 Earnings
26-02-2026
yahoo.com
BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership
26-02-2026
yahoo.com
BeOne Medicines to Present at Upcoming Investor Conferences
17-02-2026
yahoo.com
What is the current price of BEONE MEDICINES LTD-ADR (ONC:NASDAQ)?
The current price of BEONE MEDICINES LTD-ADR (ONC:NASDAQ) is $312.31.
BEONE MEDICINES LTD-ADR (ONC:NASDAQ) absolute price change since previous trading day?
The absolute price change of BEONE MEDICINES LTD-ADR (ONC:NASDAQ) since the previous trading day is $-5.76.
BEONE MEDICINES LTD-ADR (ONC:NASDAQ) percentage price change since previous trading day?
The percentage price change of BEONE MEDICINES LTD-ADR (ONC:NASDAQ) since the previous trading day is -1.8109%.
What is the most recent average sentiment score for BEONE MEDICINES LTD-ADR (ONC:NASDAQ)?
The most recent average sentiment score for BEONE MEDICINES LTD-ADR (ONC:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for BEONE MEDICINES LTD-ADR (ONC:NASDAQ)?
The most recent sentiment for BEONE MEDICINES LTD-ADR (ONC:NASDAQ) is .
SEC-8K** Filing Available For BEONE MEDICINES LTD-ADR (ONC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.